Back
Perspective Therapeutics Quote, Financials, Valuation and Earnings
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Buy
65
CATX
Perspective Therapeutics
Last Price:
13.71
Seasonality Move:
0.46%
7 Day Trial
ALL ACCESS PASS
$
7
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.Perspective Therapeutics Price Quote
$13.71
+0.09 (+0.66%)
(Updated: July 26, 2024 at 6:55 PM ET)
Perspective Therapeutics Key Stats
Buy
65
Perspective Therapeutics (CATX)
is a Buy
Day range:
$12.82 - $13.67
52-week range:
$2.05 - $19.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.99%
Volume:
1M
Avg. volume:
1.1M
1-year change:
145.89%
Market cap:
$918.2M
Revenue:
$0
EPS:
$-1.9
How Much Does Perspective Therapeutics Make?
Data Unavailable
Is Perspective Therapeutics Growing As A Company?
Data Unavailable
Perspective Therapeutics Stock Price Performance
-
Did Perspective Therapeutics Stock Go Up Last Month?
Perspective Therapeutics share price went up by 42.62% last month -
Did CATX's Share Price Rise Over The Last Year?
CATX share price rose by 145.89% over the past 1 year
What Is Perspective Therapeutics 52-Week High & Low?
-
What Is Perspective Therapeutics’s 52-Week High Share Price?
Perspective Therapeutics has traded as high as $19.05 over the past 52 weeks -
What Is Perspective Therapeutics’s 52-Week Low Share Price?
Perspective Therapeutics has traded as low as $2.05 over the past 52 weeks
Perspective Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Perspective Therapeutics?
-
How Much Debt Does Perspective Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Perspective Therapeutics Have?
Cash and short term investments quarterly total is $180.6M -
What Is Perspective Therapeutics’s Book Value Per Share?
Book value per share is 3.92
Is Perspective Therapeutics Cash Flow Positive?
-
What Is CATX Cash Flow From Operations?
Cash flow from operations (TTM) is -$13.3M -
What Is Perspective Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $167.2M -
What Is Perspective Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$48.2M
Perspective Therapeutics Return On Invested Capital
Data Unavailable
Perspective Therapeutics Earnings Date & Stock Price
-
What Is Perspective Therapeutics's Stock Price Today?
A single share of CATX can be purchased today for 13.62 -
What Is Perspective Therapeutics’s Stock Symbol?
Perspective Therapeutics trades on the nyam under the ticker symbol: CATX -
When Is Perspective Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Perspective Therapeutics is scheduled on August 9, 2024 -
When Is CATX's next ex-dividend date?
Perspective Therapeutics's next ex-dividend date is July 26, 2024 -
How To Buy Perspective Therapeutics Stock?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Perspective Therapeutics Competitors
-
Who Are Perspective Therapeutics's Competitors?
Below is a list of companies who compete with Perspective Therapeutics or are related in some way:
Perspective Therapeutics Dividend Yield
Data Unavailable
Perspective Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 22.50 |
| Upside from Last Price: | 65.2% |